How Much Reliable iv Calcium for the Treatment of Hyperkalemia?
NCT ID: NCT02672930
Last Updated: 2021-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
111 participants
OBSERVATIONAL
2015-07-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correction of Hypernatremia by Intravenous Hypotonic Solution Compared to Enteral Water
NCT06061783
Fluid Chloride and AKI in Cardiopulmonary Bypass
NCT02668952
Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation
NCT05909150
Perioperative Fluid Management in Patients Receiving Cadaveric Renal Transplants
NCT01075750
Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke
NCT06374823
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electrocardiogram (ECG)
ECG and vital parameters were obtained before and after recommended standard calcium gluconate therapy for hyperkalemia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients needed antiarrhythmic interventions
* Patients need inotropic that may cause ECG changes
* Patients need atropine during emergency treatment prior to Ca-gluconate
* Patients needed cardioversion or defibrillation
* Hyperpotassemia with myocardial infarction
* In the presence of other situations which changes ECG for example pericarditis
* Unstabile patients for ideal ECG
* Digoxin usage
* Trauma
* blood calcium level of \> 10.5 mg/dl
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haseki Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adnan Yamanoğlu
Emergency Medicine Specialist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adnan Yamanoğlu, MD
Role: PRINCIPAL_INVESTIGATOR
Emergency Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haseki Training and Reseurch Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
230
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.